107 related articles for article (PubMed ID: 24852917)
1. External beam radiation with 'curative intent' in advanced ovarian cancer: an uncommon but rational management approach based on the natural history of cancer in an individual patient.
Markman M
Oncology; 2014; 86(4):230-1. PubMed ID: 24852917
[No Abstract] [Full Text] [Related]
2. Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer.
Machida S; Takei Y; Yoshida C; Takahashi Y; Koyanagi T; Sato N; Taneichi A; Saga Y; Fujiwara H; Suzuki M
Oncology; 2014; 86(4):232-8. PubMed ID: 24853194
[TBL] [Abstract][Full Text] [Related]
3. Involved-field radiation therapy for locoregionally recurrent ovarian cancer.
Brown AP; Jhingran A; Klopp AH; Schmeler KM; Ramirez PT; Eifel PJ
Gynecol Oncol; 2013 Aug; 130(2):300-5. PubMed ID: 23648467
[TBL] [Abstract][Full Text] [Related]
4. Paraaortic node recurrence 25 years after removal of epithelial ovarian carcinoma.
Otsuka I; Shoji K
J Obstet Gynaecol Res; 2016 Nov; 42(11):1609-1612. PubMed ID: 27641229
[TBL] [Abstract][Full Text] [Related]
5. Role of radiation therapy.
Eifel PJ
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():118-125. PubMed ID: 27986398
[TBL] [Abstract][Full Text] [Related]
6. Planning treatment for women with recurrent epithelial ovarian cancer.
Tanner E; Armstrong DK
Oncology (Williston Park); 2013 Apr; 27(4):304, 306. PubMed ID: 23781694
[No Abstract] [Full Text] [Related]
7. Management of recurrent EOC: the state of the art.
Fleming GF
Oncology (Williston Park); 2013 Apr; 27(4):298, 303-4. PubMed ID: 23781693
[No Abstract] [Full Text] [Related]
8. Combining targeted therapies in ovarian cancer.
Scambia G; Salutari V; Ferrandina G
Lancet Oncol; 2014 Oct; 15(11):1179-81. PubMed ID: 25218905
[No Abstract] [Full Text] [Related]
9. Helical tomotherapy versus conventional radiation to deliver abdominopelvic radiation.
Choe J; Kulasekere R; Oddo D; Anthony S; Shin T; Murray M; Kunos CA
Technol Cancer Res Treat; 2012 Feb; 11(1):49-56. PubMed ID: 22181331
[TBL] [Abstract][Full Text] [Related]
10. Recurrent epithelial ovarian cancer: an update on treatment.
Foley OW; Rauh-Hain JA; del Carmen MG
Oncology (Williston Park); 2013 Apr; 27(4):288-94, 298. PubMed ID: 23781692
[TBL] [Abstract][Full Text] [Related]
11. [Effect of evidence-based medicine on the decision of chemotherapy for epithelial ovarian cancer].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):582-6. PubMed ID: 23141177
[No Abstract] [Full Text] [Related]
12. Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab.
Bansal N; Hoffman M
Gynecol Oncol; 2011 Feb; 120(2):313-4. PubMed ID: 21055796
[No Abstract] [Full Text] [Related]
13. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial.
Chang JS; Kim SW; Kim YJ; Kim JY; Park SY; Kim JH; Jang TK; Kim YB
Gynecol Oncol; 2018 Oct; 151(1):39-45. PubMed ID: 30146110
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of the therapeutic possibilities of systemic radiotherapy as a component of combined treatment for advanced ovarian carcinoma].
Iurkova LE; Shutko AN
Vopr Onkol; 2013; 59(4):479-82. PubMed ID: 24032223
[TBL] [Abstract][Full Text] [Related]
15. Role of chemotherapy in epithelial ovarian cancer.
Markman M
Minerva Ginecol; 2011 Jun; 63(3):287-97. PubMed ID: 21654613
[TBL] [Abstract][Full Text] [Related]
16. Trebananib: an alternative anti-angiogenic strategy.
Gourley C
Lancet Oncol; 2014 Jul; 15(8):776-7. PubMed ID: 24950984
[No Abstract] [Full Text] [Related]
17. Whole abdominal radiation using helical tomotherapy-based intensity-modulated radiotherapy: a potential for consolidation therapy in adequately treated locally advanced epithelial ovarian cancers.
Mahantshetty U; Shankar S; Engineer R; Chopra S; Gupta S; Maheshwari A; Kerkar R; Shrivastava S
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):457-8. PubMed ID: 22507834
[No Abstract] [Full Text] [Related]
18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?
Gonzalez Bayon L; Steiner MA; Vasquez Jimenez W; Asencio JM; Alvarez de Sierra P; Atahualpa Arenas F; Rodriguez del Campo J; Garcia Sabrido JL
Eur J Surg Oncol; 2013 Oct; 39(10):1109-15. PubMed ID: 23870278
[TBL] [Abstract][Full Text] [Related]
19. Combined drug therapy for ovarian carcinoma.
Li MC; Hsu KP
Clin Obstet Gynecol; 1970 Dec; 13(4):928-44. PubMed ID: 4325125
[No Abstract] [Full Text] [Related]
20. Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: its possible clinical significance.
Chuang YT; Chang CL
Taiwan J Obstet Gynecol; 2012 Sep; 51(3):336-41. PubMed ID: 23040913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
